first-in-human study

Tel Aviv, Israel, August 19, 2026 Galmed Pharmaceuticals announced successful first-in-human proof-of-concept results for a novel intraoperative tissue assessment...

Panamá City, Panamá, August 14, 2026 Nanochon, Inc., a medical device company developing regenerative solutions for cartilage repair, announced...

KIGALI, Rwanda, July 20, 2026 Akagera Medicines, Inc. has announced positive first-in-human Phase 1 results for AKG-100, its investigational...

HONG KONG, June 18, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...

BEVERLY, Mass., June 16, 2026 Akston Biosciences Corporation has announced promising preclinical data demonstrating that its investigational immunotherapeutic AKS-699...

OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...

LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...

NEW YORK, June 9, 2026 Formation Bio announced the first participant has been dosed in a Phase 1 first-in-human...

NORTH CHICAGO, Illinois, USA – June 8, 2026 AbbVie has announced the presentation of new clinical and translational research...

ENCINITAS, California, USA & WROCLAW, Poland – June 8, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies...